Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Antimalarial Drugs as Potential Treatment for Polycystic Ovary Syndrome

    Recently, a groundbreaking study published in Science has revealed that the antimalarial drug artemisinin may have potential therapeutic effects on polycystic ovary syndrome (PCOS). PCOS is a complex endocrine disorder primarily affecting women of reproductive age. It is characterized by persistent anovulation, hyperandrogenism, and insulin resistance. Clinically, it manifests as irregular menstrual cycles, enlarged ovaries…

    2024.08.09
  • AIDS 2024丨Long-Acting Injectable CAB/RPV in Adolescents and Young Adults with HIV: 26-Month Cohort Study Results

    From July 22 to 26, 2024, the 25th International AIDS Conference (AIDS 2024) took place in Munich, Germany, attracting 15,000 professionals and advocates worldwide to discuss the latest advancements and future challenges in HIV prevention and treatment. At the conference, a research team from Children’s National Hospital in the United States, along with several collaborating…

    2024.08.09
  • Comprehensive Review of Chemotherapy-Induced Anemia Management in China (2)

    Cancer-related anemia (CRA) encompasses anemia that occurs in cancer patients during disease progression or treatment, including non-chemotherapy-related CRA and chemotherapy-induced anemia (CIA). With the increase in chemotherapy treatments, the incidence of anemia is significant, with over 90% of patients not receiving any corrective treatment. To gain a comprehensive understanding of the current practices and perceptions…

    2024.08.09
  • JAMA Sub-Journal丨Breast Cancer Incidence Following False-Positive Mammogram Results

    Mammography is the only imaging method proven to detect breast cancer early and reduce patient mortality; however, traditional mammography often yields false-positive results, and the long-term outcomes of these false positives remain unclear. Recently, a Swedish study involving 497,343 women found that the risk of breast cancer following a false-positive mammogram varies based on personal…

    2024.08.09
  • Leading Experts Discuss Current and Future Immunotherapy for TNBC, Guiding Precision Treatment Development丨2024 Breast Cancer Summer Forum·

    On July 27-28, 2024, the “2024 Breast Cancer Summer Forum·Northern Salon” was grandly held at the Shougang Park in Beijing. The conference adhered to the concept of “learning, absorbing, innovating, and improving” and embraced the tradition of “All directions, Throughout time and across the world, Across all seasons, People of all ages and genders” offering…

    2024.08.09
  • Dr. Fu Fu Zheng: New Advances in Prostate Cancer Research at the 2024 ASCO Meeting 🌟 | Real-World Exploration and AI Applications in Prostate Cancer Pathology

    Prostate cancer is a common malignant tumor of the reproductive system, particularly affecting elderly men. Screening high-risk populations and tailoring treatment plans based on patient characteristics are crucial for improving cure rates and enhancing quality of life. Recently, the 2024 ASCO Annual Meeting unveiled numerous advancements in the treatment of prostate cancer. “Oncology Frontier” invited…

    2024.08.09
  • Dr. Fu Fu Zheng: New Advances in Prostate Cancer Research at the 2024 ASCO Meeting (Real-World Exploration and Learning from Others)

    Prostate cancer is a common malignant tumor of the reproductive system, particularly affecting elderly men. Screening high-risk populations and tailoring treatment plans based on patient characteristics are crucial for improving cure rates and enhancing quality of life. Recently, the 2024 ASCO Annual Meeting unveiled numerous advancements in the treatment of prostate cancer. “Oncology Frontier” invited…

    2024.08.09
  • 2024 COMB丨Dr. Fei Ma: Metronomic Chemotherapy Combined with Immunotherapy Opens a New Chapter in Breast Cancer Research

    In the field of breast cancer treatment, innovative therapies are emerging constantly, yet many issues still urgently need to be addressed. Recently, Academician Binghe Xu and Dr. Fei Ma from the Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College published an article in Nature Medicine titled “Metronomic chemotherapy plus anti-PD-1…

    2024.08.09
«previous next»
Recent Posts
  • CSCO 2026 | Professor Yanxia Shi: Extending Endocrine-Based Treatment — CDK2/4/6 Inhibition Offers a Therapeutic Option for Mutation-Negative Patients After CDK4/6 Inhibitor Therapy
  • CSCO 2026 | Professor Biyun Wang: From Stratification to Precision — Treatment Strategies After CDK4/6 Inhibitor Resistance and the Clinical Positioning of the CDK2/4/6 Inhibitor Kermoxili
  • CSCO International Perspectives | Professor Kun Wang in Conversation With Professor Pier Paolo Berton Giachetti: From Experience to Evidence — The Path Toward Precision Treatment in Early HER2-Positive Breast Cancer
  • ESMO Preview | Professor Yongmei Yin: A New Breakthrough in HR+/HER2− Advanced Breast Cancer — Iza-bren Ushers in a New Era of Bispecific ADC Therapy
  • Personalized mRNA Vaccine Plus Pembrolizumab Reduces Recurrence and Metastasis in Melanoma
Recent Comments
    Archives
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top